Capital and pipelines are the pillars upon which successful pharma companies stand.  Given the complexity of taking a molecule from the bench to the bedside, few, if any organizations have both the capital and the pipeline to go it alone today.  We assist the movement of these critical assets across corporate boundaries through our extensive network of personal relationships within industry, finance and academia and our knowledge of the competitive space. 

  • Identification of product/technology licensing opportunities
  • Due diligence for in-licensing opportunities
  • Identification of potential partners for out-licensing
  • Acquisition of capital
  • Competitive analysis
  • Portfolio optimization